Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen - Aix-Marseille Université Access content directly
Journal Articles Pharmacogenomics Year : 2013

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

Domains

Cancer
No file

Dates and versions

hal-01708020 , version 1 (13-02-2018)

Identifiers

Cite

Cindy Serdjebi, Jean-François Seitz, Joseph Ciccolini, Muriel Duluc, Emmanuelle Norguet, et al.. Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen. Pharmacogenomics, 2013, 14 (9), pp.1047 - 1051. ⟨10.2217/pgs.13.93⟩. ⟨hal-01708020⟩
34 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More